In other words, achieving guideline-directed hypertension treatment goals in a 35-year-old with only hypertension is a different matter from managing hypertension in an 85-year-old with dementia, chronic dizziness, incontinence and chronic kidney disease.
Because of the high prevalence of co morbidities in CKD patients, achieving guideline-based targets may be difficult.
Achieving guideline activity levels was associated with a 25%% lower mortality rate in adjusted models (HR, 95 % CI 0.75, 0.58 0.97), compared with being inactive.
For the assessment of achieving guideline target lab values, every relevant analyte in every available accession was included for each patient.
Four areas for achieving guideline development success included: broad agreements and consensus about scope and purpose of the guidelines, a formalized and structured development procedure, systematic and active involvement of stakeholders, and openness and transparency in the guideline development process.
At 1 year, body weight decreased by 8.6% and the percentage of participants with A1C <7% increased from 46to7373% with a doubling (from 10 to 23.6%) of those achieving guideline goals for glycemic, blood pressure, and lipid control (12).
Patients were treated to achieve guideline-recommended BP (<140 mm Hg/<90 mm Hg; diabetes: <130 mm Hg/<80 mm Hg).
The key lipid-lowering target is to achieve guideline-recommended low-density lipoprotein cholesterol (LDL-C) levels, usually by using statins.
The majority of patients with myocardial infarction (MI) and hypercholesterolaemia does not achieve guideline recommended low-density lipoprotein cholesterol (LDL) levels.
The multiple-barrier concept is widely employed in international and domestic guidelines for wastewater reclamation and reuse for microbiological risk management, in which a wastewater reclamation system is designed to achieve guideline values of the performance target of microbe reduction.
